03 August 2020
: Case report
Thymolipoma Association with Myasthenia Gravis: Case Report
Rare coexistence of disease or pathology
Sharifah A. Othman1BEF, Othman Y. AlFrayyan1EF, Zeead M. AlGhamdi1ACDEF*, Fahd Makhdom2E, Yasser AlJehani1E, Hatem Y. Elbawab1E, Mohamed El-Shawarby3EDOI: 10.12659/AJCR.923989
Am J Case Rep 2020; 21:e923989
Related articles
13 Feb 2020 : Animal Research
Effect of Grilled Nux Vomica on Differential RNA Expression Profile of Gastrocnemius Muscle and Toll‑Like Receptor 4 (TLR-4)/Nuclear Factor kappa B (NF-κB) Signaling in Experimental Autoimmune Myasthenia Gravis Rats
Xu Hong Jiang, Yi Chen
DOI: 10.12659/MSM.919150
Med Sci Monit 2020; 26:e919150
17 May 2020 : Case report
Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report
Gregory T. Greenwood, Zachary Lynch
DOI: 10.12659/AJCR.921431
Am J Case Rep 2020; 21:e921431
13 Sep 2020 : Animal Research
AEB-071 Ameliorates Muscle Weakness by Altering Helper T Lymphocytes in an Experimental Autoimmune Myasthenia Gravis Rat Model
Feng Jing, Wei Huang
DOI: 10.12659/MSM.924393
Med Sci Monit 2020; 26:e924393
06 Jul 2019 : Case report
Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case Series
Todd D. Levine,
DOI: 10.12659/AJCR.916424
Am J Case Rep 2019; 20:965-970
26 Sep 2019 : Case report
Pyridostigmine Suicidal Attempt in a Myasthenia Gravis Patient
Mohammed Aref T. Malabaey, Ahad A. Al-Saud
DOI: 10.12659/AJCR.917308
Am J Case Rep 2019; 20:1418-1421
20 Nov 2019 : Case report
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3
Mizuki Gobaru, Kenji Ashida
DOI: 10.12659/AJCR.918996
Am J Case Rep 2019; 20:1709-1714
09 Mar 2017 : Clinical Research
Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent
Guoyan Qi, Peng Liu
DOI: 10.12659/MSM.902442
Med Sci Monit 2017; 23:1217-1223
20 Apr 2017 : Case report
Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review
Michael Sherpa, Ravi K. Metai
DOI: 10.12659/AJCR.903108
Am J Case Rep 2017; 18:427-430
29 Jan 2016 : Case report
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment
Flávio Adsuara Cadegiani,
DOI: 10.12659/AJCR.894849
Am J Case Rep 2016; 17:51-54
19 Jun 2015 : Animal Research
miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice
Lei Shi, Tiantian Liu
DOI: 10.12659/MSM.893458
Med Sci Monit 2015; 21:1774-1780
30 Aug 2015 : Meta-Analysis
PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis
Xunbo Xiong, Mingqing Xiang
DOI: 10.12659/MSM.894307
Med Sci Monit 2015; 21:2567-2571
11 Sep 2013 : Case report
Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis
Sarmad Said, Chad J. Cooper
DOI: 10.12659/AJCR.889484
Am J Case Rep 2013; 14:359-361
01 Dec 2004
Respiratory failure as a first presentation of myasthenia gravis
Adnan I. Qureshi, Mohammad A. Choudhry
Med Sci Monit 2004; 10(12): CR684-689
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945747
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945539
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945795
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946588
Most Viewed Current Articles
21 Jun 2024 : Case report
88,518
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,005
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,154
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,640
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030